{
  "id": 6,
  "title": "Substance Use and Abuse",
  "description": "Understanding substance use disorders, withdrawal management, and nursing interventions.",
  "objectives": [
    "Differentiate substance abuse, dependence, intoxication, and withdrawal",
    "Identify and manage alcohol withdrawal using the CIWA scale",
    "Implement appropriate nursing interventions for substance use disorders",
    "Recognize enabling behaviors and appropriate family interventions"
  ],
  "content": "\n      <h3>Substance Use Disorder (DSM-5)</h3>\n      <p>A pathological pattern of substance use leading to significant impairment or distress, with 11 criteria grouped into four categories:</p>\n      \n      <h4>Impaired Control</h4>\n      <ul>\n        <li>Using larger amounts or for longer than intended</li>\n        <li>Persistent desire or unsuccessful efforts to cut down</li>\n        <li>Great deal of time obtaining, using, or recovering</li>\n        <li>Craving or strong urge to use</li>\n      </ul>\n\n      <h4>Social Impairment</h4>\n      <ul>\n        <li>Failure to fulfill role obligations</li>\n        <li>Continued use despite social/interpersonal problems</li>\n        <li>Giving up important activities because of use</li>\n      </ul>\n\n      <h4>Risky Use</h4>\n      <ul>\n        <li>Use in physically hazardous situations</li>\n        <li>Continued use despite physical/psychological problems</li>\n      </ul>\n\n      <h4>Pharmacological Criteria</h4>\n      <ul>\n        <li><strong>Tolerance:</strong> Need for increased amounts for same effect</li>\n        <li><strong>Withdrawal:</strong> Characteristic syndrome when stopping use</li>\n      </ul>\n\n      <h3>Alcohol Withdrawal and CIWA Scale</h3>\n      \n      <h4>Alcohol Withdrawal Timeline</h4>\n      <ul>\n        <li><strong>6-12 hours:</strong> Tremors, anxiety, headache, nausea</li>\n        <li><strong>12-24 hours:</strong> Hallucinations (usually visual)</li>\n        <li><strong>48-96 hours:</strong> Seizures possible</li>\n        <li><strong>3-5 days:</strong> Delirium tremens (medical emergency)</li>\n      </ul>\n\n      <h4>CIWA-Ar Scale Components</h4>\n      <ol>\n        <li><strong>Nausea/Vomiting:</strong> 0-7 points</li>\n        <li><strong>Tremor:</strong> 0-7 points</li>\n        <li><strong>Paroxysmal Sweats:</strong> 0-7 points</li>\n        <li><strong>Anxiety:</strong> 0-7 points</li>\n        <li><strong>Agitation:</strong> 0-7 points</li>\n        <li><strong>Tactile Disturbances:</strong> 0-7 points</li>\n        <li><strong>Auditory Disturbances:</strong> 0-7 points</li>\n        <li><strong>Visual Disturbances:</strong> 0-7 points</li>\n        <li><strong>Headache/Fullness in Head:</strong> 0-7 points</li>\n        <li><strong>Orientation:</strong> 0-4 points</li>\n      </ol>\n\n      <h4>CIWA Scoring and Interventions</h4>\n      <ul>\n        <li><strong>0-9:</strong> Minimal symptoms, supportive care</li>\n        <li><strong>10-15:</strong> Mild to moderate symptoms, consider medication</li>\n        <li><strong>16+:</strong> Severe symptoms, medication indicated</li>\n      </ul>\n\n      <h3>Common Substances and Effects</h3>\n      \n      <h4>Depressants</h4>\n      <ul>\n        <li><strong>Alcohol:</strong> CNS depression, disinhibition</li>\n        <li><strong>Benzodiazepines:</strong> Anxiety relief, sedation</li>\n        <li><strong>Opioids:</strong> Pain relief, euphoria, respiratory depression</li>\n      </ul>\n\n      <h4>Stimulants</h4>\n      <ul>\n        <li><strong>Cocaine:</strong> Euphoria, increased energy, cardiac risks</li>\n        <li><strong>Amphetamines:</strong> Alertness, appetite suppression</li>\n        <li><strong>Caffeine:</strong> Increased alertness, potential anxiety</li>\n      </ul>\n\n      <h4>Hallucinogens</h4>\n      <ul>\n        <li><strong>LSD:</strong> Perceptual distortions, \"flashbacks\"</li>\n        <li><strong>Cannabis:</strong> Relaxation, altered perception, memory impairment</li>\n      </ul>\n\n      <h3>Nursing Interventions</h3>\n      \n      <h4>Acute Care</h4>\n      <ul>\n        <li>Monitor vital signs and withdrawal symptoms</li>\n        <li>Administer medications as ordered (benzodiazepines, vitamins)</li>\n        <li>Maintain safe environment</li>\n        <li>Provide emotional support and reassurance</li>\n        <li>Monitor for complications (seizures, delirium)</li>\n      </ul>\n\n      <h4>Long-term Recovery</h4>\n      <ul>\n        <li>Education about disease process</li>\n        <li>Coping skills training</li>\n        <li>Relapse prevention planning</li>\n        <li>Support group referrals (AA, NA)</li>\n        <li>Family therapy and education</li>\n      </ul>\n\n      <h3>Family Dynamics and Codependency</h3>\n      \n      <h4>Enabling Behaviors</h4>\n      <ul>\n        <li>Making excuses for substance user</li>\n        <li>Covering consequences of use</li>\n        <li>Providing money or resources</li>\n        <li>Denying problem exists</li>\n      </ul>\n\n      <h4>Codependency Characteristics</h4>\n      <ul>\n        <li>Excessive focus on controlling others</li>\n        <li>Low self-esteem and self-worth</li>\n        <li>Difficulty setting boundaries</li>\n        <li>Taking responsibility for others' problems</li>\n      </ul>\n\n      <h3>Special Populations</h3>\n      \n      <h4>Healthcare Professionals</h4>\n      <ul>\n        <li>Higher risk due to access and stress</li>\n        <li>Professional reporting obligations</li>\n        <li>Alternative-to-discipline programs</li>\n        <li>Importance of early intervention</li>\n      </ul>\n\n      <h4>Adolescents</h4>\n      <ul>\n        <li>Developmental considerations</li>\n        <li>Family involvement in treatment</li>\n        <li>School-based interventions</li>\n        <li>Peer influence factors</li>\n      </ul>\n    "
}